SYNLOGIC, INC. Variable Lease, Cost
SYNLOGIC, INC. (SYBX) reported Variable Lease, Cost of $1.09 million for the 12-month period ending 2024-12-31, per its 10-K filed 2025-03-06.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:VariableLeaseCost · last filed 2025-03-06
- SYNLOGIC, INC. variable lease, cost for the quarter ending 2019-12-31 was $298.00K.
- SYNLOGIC, INC. variable lease, cost for the quarter ending 2019-09-30 was $268.00K.
- SYNLOGIC, INC. variable lease, cost for the quarter ending 2019-06-30 was $268.00K.
- SYNLOGIC, INC. variable lease, cost for the quarter ending 2019-03-31 was $263.00K.
- SYNLOGIC, INC. variable lease, cost for fiscal 2024 was $1.09M, a 31.08% decline from fiscal 2023.
- SYNLOGIC, INC. variable lease, cost for fiscal 2023 was $1.58M, a 12.35% increase from fiscal 2022.
- SYNLOGIC, INC. variable lease, cost for fiscal 2022 was $1.41M, a 6.07% decline from fiscal 2021.
- SYNLOGIC, INC. variable lease, cost for fiscal 2021 was $1.50M, a 42.18% increase from fiscal 2020.
| Period end | Variable Lease, Cost 3 month | Variable Lease, Cost 6 month | Variable Lease, Cost 9 month | Variable Lease, Cost 12 month |
|---|---|---|---|---|
| 2024-12-31 | $1.09M 10-K · filed 2025-03-06 | |||
| 2023-12-31 | $1.58M 10-K · filed 2025-03-06 | |||
| 2022-12-31 | $1.41M 10-K · filed 2024-03-19 | |||
| 2021-12-31 | $1.50M 10-K · filed 2023-03-29 | |||
| 2020-12-31 | $1.05M 10-K · filed 2022-03-17 | |||
| 2019-12-31 | $298.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-25 | $566.00K derived: sum of 2 quarters · filed 2021-03-25 | $834.00K derived: sum of 3 quarters · filed 2021-03-25 | $1.09M 10-K · filed 2021-03-25 |
| 2019-09-30 | $268.00K 10-Q · filed 2019-11-12 | $536.00K derived: sum of 2 quarters · filed 2019-11-12 | $794.00K 10-Q · filed 2019-11-12 | |
| 2019-06-30 | $268.00K 10-Q · filed 2019-08-08 | $531.00K 10-Q · filed 2019-08-08 | ||
| 2019-03-31 | $263.00K 10-Q · filed 2019-05-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |